We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock

Delisted

NURO was delisted on the 1st of May, 2025.

12 hedge funds and large institutions have $776K invested in NeuroMetrix, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less capital invested

Capital invested by funds: $812K → $776K (-$35.7K)

20% less funds holding

Funds holding: 1512 (-3)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
12
Holders Change
-3
Holders Change %
-20%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change

NURO Hedge Fund Activity: Q1 2023 in Review

12 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q1 2023, worth a combined $776K — down 4.4% from $812K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of NURO and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was UBS Group, opening a new position worth an estimated $6.75K. The largest seller was Millennium Management, exiting entirely with an estimated $30K sold.

  • 12 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q1 2023, down from 15 in Q4 2022.
  • Funds reported $776K of NeuroMetrix, Inc. Common Stock stock for Q1 2023, down 4.4% quarter-over-quarter.
  • 1 fund opened new NeuroMetrix, Inc. Common Stock positions in Q1 2023 and 4 closed out, a net change of -3 holders.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q1 2023 was UBS Group, an estimated $6.75K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q1 2023 was Millennium Management, an estimated $30K sold.

Based on aggregated 13F filings for Q1 2023.